<DOC>
	<DOCNO>NCT01207752</DOCNO>
	<brief_summary>The aim study determine efficacy novel , lipid-containing artificial tear sign symptom meibomian gland disease .</brief_summary>
	<brief_title>The Efficacy Ocular Emulsion Meibomian Gland Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Schein symptom score ( 6 question ) great 5 , evidence MGD change eye ( i.e. , low eyelid secretion quality score great 1.0 ( 0 3 scale ) OR gland dropout score great 1.0 ( i.e. , great 25 % entire low eyelid ) demonstrate meiboscopy , corneal stain grade 4.0 great ( 0 20 scale ) . contact lens wear , use topical ocular medication artificial tear ( use Restasis specifically exclude ) , unstable systemic medication use ( i.e. , antihistamine , steroid , etc . ) , recent ( within 6 month study start ) ocular trauma surgery , diabetes , aqueous deficient dry eye ( defined Schirmer I value ( without anesthetic ) &lt; 5 mm wet 5 minute either eye ) , use punctal plug . Subjects take omega 3 fatty acid supplement dry eye include long intake stable prior six month meet inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>dry eye , meibomian gland dysfunction , tear film break time</keyword>
</DOC>